Vytrus Biotech, S.A.

Vytrus Biotech develops and manufactures ingredients that cosmetic brands use in skin and hair products. It grows plant cells and uses other biotechnology processes to produce compounds for formulations such as moisturisers and scalp treatments.

Log in to follow
VYT · BME Growth

Overview

Summary

Founded in 2009 and based in Terrassa near Barcelona, Vytrus supplies cosmetic manufacturers rather than selling finished beauty products to consumers. Plant-cell cultures provide the basis for much of its range. In 2026 it added products from recombinant-protein and microbial-fermentation platforms. Its customers receive an ingredient, supporting test data and help with formulation. An international distributor network extends its reach; its products had been sold in 52 countries by June 2026. This is cosmetic biotechnology, not clinical drug development.

Latest results

Revenue
EUR 8.6 million
Operating profit
EUR 3.0 million+84.2%
Cash held
EUR 3.9 million+18.2%
Financial debt
EUR 2.0 million

Latest financial publication

Nov 5, 2026 · Issuer publication

9M 2026 financial results

Search companies & research

Search companies & research